InvestorsHub Logo

couldbebetter

12/10/19 8:24 AM

#232460 RE: Atom0aks #232459

AtomOaks, The interview was pathetic...neither party knew what they were
talking about and neither knew how to pronounce Vascepa. Such reporting
by Reuters cheapens their entire news operation.

eightisenough

12/10/19 9:10 AM

#232467 RE: Atom0aks #232459

"I don't think Reuters was talking about a buyout"--listen again tom, the interviewer asked the analyst which other healthcare stock is he following re: a buyout and miller, the analyst, said amrn.

the analyst adam miller, that you are degrading, is a lot more successful than anyone on this board.

If he got one fact wrong about the evaporate study and mineral oil --not the end of world.

AGAIN the point is a Reuter interviewer who was very good, discussed amrn bo....gl to your short position :)